| C9014 |
Injection, cerliponase alfa |
Injection, cerliponase alfa, 1 mg |
| C9015 |
C-1 esterase, haegarda |
Injection, c-1 esterase inhibitor (human), haegarda, 10 units |
| C9016 |
Inj, triptorelin ext rel |
Injection, triptorelin extended release, 3.75 mg |
| C9021 |
Injection, obinutuzumab |
Injection, obinutuzumab, 10 mg |
| C9022 |
Injection, elosulfase alfa |
Injection, elosulfase alfa, 1mg |
| C9023 |
Inj testosterone undecanoate |
Injection, testosterone undecanoate, 1 mg |
| C9024 |
Inj, daunorubicin-cytarabine |
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
| C9025 |
Injection, ramucirumab |
Injection, ramucirumab, 5 mg |
| C9026 |
Injection, vedolizumab |
Injection, vedolizumab, 1 mg |
| C9027 |
Injection, pembrolizumab |
Injection, pembrolizumab, 1 mg |
| C9028 |
Inj. inotuzumab ozogamicin |
Injection, inotuzumab ozogamicin, 0.1 mg |
| C9029 |
Injection, guselkumab |
Injection, guselkumab, 1 mg |
| C9030 |
Inj copanlisib |
Injection, copanlisib, 1 mg |
| C9031 |
Lutetium lu 177 dotatate, tx |
Lutetium lu 177, dotatate, therapeutic, 1 mci |
| C9032 |
Voretigene neparvovec-rzyl |
Injection, voretigene neparvovec-rzyl, 1 billion vector genome |
| C9033 |
Inj, akynzeo |
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg |
| C9034 |
Injection, dexamethasone 9% |
Injection, dexamethasone 9%, intraocular, 1 mcg |
| C9035 |
Injection, aristada initio |
Injection, aripiprazole lauroxil (aristada initio), 1 mg |
| C9036 |
Injection, patisiran |
Injection, patisiran, 0.1 mg |
| C9037 |
Injection, risperidone |
Injection, risperidone (perseris), 0.5 mg |
| C9038 |
Inj mogamulizumab-kpkc |
Injection, mogamulizumab-kpkc, 1 mg |
| C9039 |
Injection, plazomicin |
Injection, plazomicin, 5 mg |
| C9040 |
Injection, fremanezumab-vfrm |
Injection, fremanezumab-vfrm, 1mg |
| C9041 |
Inj, coagulation factor xa |
Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg |
| C9042 |
Inj., belrapzo 1 mg |
Injection, bendamustine hcl (belrapzo), 1 mg |
| C9043 |
Injection, levoleucovorin |
Injection, levoleucovorin, 1 mg |
| C9044 |
Injection, cemiplimab-rwlc |
Injection, cemiplimab-rwlc, 1 mg |
| C9045 |
Moxetumomab pasudotox-tdfk |
Injection, moxetumomab pasudotox-tdfk, 0.01 mg |
| C9046 |
Cocaine hcl nasal (goprelto) |
Cocaine hydrochloride nasal solution (goprelto), 1 mg |
| C9047 |
Injection, caplacizumab-yhdp |
Injection, caplacizumab-yhdp, 1 mg |
| C9048 |
Dexamethasone ophth insert |
Dexamethasone, lacrimal ophthalmic insert, 0.1 mg |
| C9049 |
Injection, tagraxofusp-erzs |
Injection, tagraxofusp-erzs, 10 mcg |
| C9050 |
Injection, emapalumab-lzsg |
Injection, emapalumab-lzsg, 1 mg |
| C9051 |
Injection, omadacycline |
Injection, omadacycline, 1 mg |
| C9052 |
Injection, ravulizumab-cwv |
Injection, ravulizumab-cwvz, 10 mg |
| C9053 |
Inj, crizanlizumab-tmca |
Injection, crizanlizumab-tmca, 1 mg |
| C9054 |
Injection, lefamulin |
Injection, lefamulin (xenleta), 1 mg |
| C9055 |
Inj, brexanolone |
Injection, brexanolone, 1mg |
| C9056 |
Injection, givosiran |
Injection, givosiran, 0.5 mg |
| C9057 |
Inj cetirizine hydrochloride |
Injection, cetirizine hydrochloride, 1 mg |
| C9058 |
Injection,pegfilgrastim-bmez |
Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg |
| C9059 |
Injection, meloxicam |
Injection, meloxicam, 1 mg |
| C9060 |
Fluoroestradiol f18 |
Fluoroestradiol f18, diagnostic, 1 mci |
| C9061 |
Injection, teprotumumab-trbw |
Injection, teprotumumab-trbw, 10 mg |
| C9062 |
Daratumumab hyaluronidase |
Injection, daratumumab 10 mg and hyaluronidase-fihj |
| C9063 |
Injection, eptinezumab-jjmr |
Injection, eptinezumab-jjmr, 1 mg |
| C9064 |
Mitomycin pyelocalyceal inst |
Mitomycin pyelocalyceal instillation, 1 mg |
| C9065 |
Romidepsin non-lyophilized |
Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg |
| C9066 |
Sacituzumab govitecan-hziy |
Injection, sacituzumab govitecan-hziy, 2.5 mg |
| C9067 |
Gallium ga-68 dotatoc |
Gallium ga-68, dotatoc, diagnostic, 0.01 mci |
| C9068 |
Copper cu-64, dotatate, dx |
Copper cu-64, dotatate, diagnostic, 1 millicurie |
| C9069 |
Belantamab mafodontin-blmf |
Injection, belantamab mafodontin-blmf, 0.5 mg |
| C9070 |
Injection, tafasitamab-cxix |
Injection, tafasitamab-cxix, 2 mg |
| C9071 |
Injection, viltolarsen |
Injection, viltolarsen, 10 mg |
| C9072 |
Inj, imm glob asceniv |
Injection, immune globulin (asceniv), 500 mg |
| C9073 |
Brexucabtagene autoleucel ca |
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose |
| C9074 |
Injection, lumasiran |
Injection, lumasiran, 0.5 mg |
| C9075 |
Injection, casimersen, 10 mg |
Injection, casimersen, 10 mg |
| C9076 |
Lisocabtagene car pos t |
Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose |
| C9077 |
Inj cabotegravir/rilpivirine |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
| C9078 |
Inj, trilaciclib, 1 mg |
Injection, trilaciclib, 1 mg |
| C9079 |
Inj, evinacumab-dgnb, 5 mg |
Injection, evinacumab-dgnb, 5 mg |
| C9080 |
Inj, melphalan flufen, 1 mg |
Injection, melphalan flufenamide hydrochloride, 1 mg |
| C9081 |
Idecabtagene car pos t |
Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose |
| C9082 |
Inj dostarlimab-gxly, 100 mg |
Injection, dostarlimab-gxly, 100 mg |
| C9083 |
Inj, amivantamab-vmjw, 10 mg |
Injection, amivantamab-vmjw, 10 mg |
| C9084 |
Loncastuximab-lpyl, 0.1 mg |
Injection, loncastuximab tesirine-lpyl, 0.1 mg |
| C9085 |
Inj avalglucosid alfa-ngpt |
Injection, avalglucosidase alfa-ngpt, 4 mg |
| C9086 |
Inj, anifrolumab-fnia |
Injection, anifrolumab-fnia, 1 mg |
| C9087 |
Inj cyclophosphamd auromedic |
Injection, cyclophosphamide, (auromedics), 10 mg |
| C9088 |
Instill, bupivac and meloxic |
Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg |
| C9089 |
Bupivacaine implant, 1 mg |
Bupivacaine, collagen-matrix implant, 1 mg |
| C9090 |
Plasminogen, human-tvmh 1 mg |
Injection, plasminogen, human-tvmh, 1 mg |
| C9091 |
Sirolimus, protein-bound,1mg |
Injection, sirolimus protein-bound particles, 1 mg |
| C9092 |
Inj., xipere, 1 mg |
Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg |
| C9093 |
Inj., susvimo, 0.1 mg |
Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg |
| C9094 |
Inj, sutimlimab-jome, 10 mg |
Inj, sutimlimab-jome, 10 mg |
| C9095 |
Inj, tebentafusp-tebn, 1 mcg |
Inj, tebentafusp-tebn, 1 mcg |
| C9096 |
Inj, releuko, 1 mcg |
Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram |
| C9097 |
Inj, faricimab-svoa, 0.1 mg |
Inj, faricimab-svoa, 0.1 mg |
| C9098 |
Ciltacabtagene car pos t |
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose |
| C9101 |
Inj, oliceridine 0.1 mg |
Injection, oliceridine, 0.1 mg |
| C9113 |
Inj pantoprazole sodium, via |
Injection, pantoprazole sodium, per vial |
| C9121 |
Injection, argatroban |
Injection, argatroban, per 5 mg |
| C9122 |
Mometasone furoate (sinuva) |
Mometasone furoate sinus implant, 10 micrograms (sinuva) |
| C9132 |
Kcentra, per i.u. |
Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity |
| C9133 |
Factor ix recombinant |
Factor ix (antihemophilic factor, recombinant), rixubis, per i.u. |
| C9134 |
Factor xiii a-subunit recomb |
Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. |
| C9135 |
Factor ix (alprolix) |
Factor ix (antihemophilic factor, recombinant), alprolix, per i.u. |
| C9136 |
Factor viii (eloctate) |
Injection, factor viii, fc fusion protein, (recombinant), per i.u. |
| C9137 |
Adynovate factor viii recom |
Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u. |
| C9138 |
Nuwiq factor viii recomb |
Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u. |
| C9139 |
Idelvion, 1 i.u. |
Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u. |
| C9140 |
Afstyla factor viii recomb |
Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u. |
| C9141 |
Factor viii pegylated-aucl |
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u. |
| C9142 |
Inj, alymsys, 10 mg |
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg |
| C9143 |
Cocaine hcl nasal (numbrino) |
Cocaine hydrochloride nasal solution (numbrino), 1 mg |
| C9144 |
Inj, bupivacaine (posimir) |
Injection, bupivacaine (posimir), 1 mg |
| C9145 |
Inj, aponvie, 1 mg |
Injection, aprepitant, (aponvie), 1 mg |
| C9146 |
Inj, elahere, 1 mg |
Injection, mirvetuximab soravtansine-gynx, 1 mg |
| C9147 |
Inj, tremelimumab-actl, 1 mg |
Injection, tremelimumab-actl, 1 mg |
| C9148 |
Inj, teclistamab-cqyv, 0.5mg |
Injection, teclistamab-cqyv, 0.5 mg |
| C9149 |
Inj, teplizumab-mzwv, 5 mcg |
Injection, teplizumab-mzwv, 5 mcg |
| C9150 |
Xe129 xenon, diagnostic |
Xenon xe-129 hyperpolarized gas, diagnostic, per study dose |
| C9151 |
Inj, pegcetacoplan 1 mg |
Injection, pegcetacoplan, 1 mg |
| C9152 |
Inj, abilify asimtufii, 1 mg |
Injection, aripiprazole, (abilify asimtufii), 1 mg |
| C9153 |
Inj, amisulpride, 1 mg |
Injection, amisulpride, 1 mg |
| C9154 |
Inj buprenorph (brixadi) 1mg |
Injection, buprenorphine extended-release (brixadi), 1 mg |
| C9155 |
Inj epcoritamab-bysp,0.16 mg |
Injection, epcoritamab-bysp, 0.16 mg |
| C9156 |
Flotufolastat f18, dia 1 mci |
Flotufolastat f 18, diagnostic, 1 millicurie |
| C9157 |
Inj, tofersen, 1 mg |
Injection, tofersen, 1 mg |
| C9158 |
Inj, uzedy, 1 mg |
Injection, risperidone, (uzedy), 1 mg |
| C9159 |
Inj, balfaxar, per i.u |
Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity |
| C9160 |
Inj daxibotulinumtoxina-lanm |
Injection, daxibotulinumtoxina-lanm, 1 unit |
| C9161 |
Inj, aflibercept hd, 1 mg |
Injection, aflibercept hd, 1 mg |
| C9162 |
Inj, avacincaptad peg 0.1 mg |
Injection, avacincaptad pegol, 0.1 mg |
| C9163 |
Inj talquetamab-tgvs 0.25 mg |
Injection, talquetamab-tgvs, 0.25 mg |
| C9164 |
Cantharidin top, applicator |
Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) |
| C9165 |
Inj, elranatamab-bcmm, 1 mg |
Injection, elranatamab-bcmm, 1 mg |
| C9166 |
Injection, secukinumab |
Injection, secukinumab, intravenous, 1 mg |
| C9167 |
Inj, adzynma, 10 iu |
Injection, adamts13, recombinant-krhn, 10 iu |
| C9168 |
Injection, mirikizumab-mrkz |
Injection, mirikizumab-mrkz, 1 mg |
| C9248 |
Inj, clevidipine butyrate |
Injection, clevidipine butyrate, 1 mg |
| C9250 |
Artiss fibrin sealant |
Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml |
| C9254 |
Injection, lacosamide |
Injection, lacosamide, 1 mg |
| C9257 |
Bevacizumab injection |
Injection, bevacizumab, 0.25 mg |
| C9275 |
Hexaminolevulinate hcl |
Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose |
| C9285 |
Patch, lidocaine/tetracaine |
Lidocaine 70 mg/tetracaine 70 mg, per patch |
| C9290 |
Inj, bupivacaine liposome |
Injection, bupivacaine liposome, 1 mg |
| C9293 |
Injection, glucarpidase |
Injection, glucarpidase, 10 units |
| C9349 |
Puraply, puraply antimic |
Puraply, and puraply antimicrobial, any type, per square centimeter |
| C9352 |
Neuragen nerve guide, per cm |
Microporous collagen implantable tube (neuragen nerve guide), per centimeter length |
| C9353 |
Neurawrap nerve protector,cm |
Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length |
| C9354 |
Veritas collagen matrix, cm2 |
Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter |
| C9355 |
Neuromatrix nerve cuff, cm |
Collagen nerve cuff (neuromatrix), per 0.5 centimeter length |
| C9356 |
Tenoglide tendon prot, cm2 |
Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter |
| C9358 |
Surgimend, fetal |
Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters |
| C9359 |
Implnt,bon void filler-putty |
Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc |
| C9360 |
Surgimend, neonatal |
Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters |
| C9361 |
Neuromend nerve wrap |
Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length |
| C9362 |
Implnt,bon void filler-strip |
Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc |
| C9363 |
Integra meshed bil wound mat |
Skin substitute, integra meshed bilayer wound matrix, per square centimeter |
| C9364 |
Porcine implant, permacol |
Porcine implant, permacol, per square centimeter |
| C9399 |
Unclassified drugs or biolog |
Unclassified drugs or biologicals |
| C9407 |
Iodine i-131 iobenguane, dx |
Iodine i-131 iobenguane, diagnostic, 1 millicurie |
| C9408 |
Iodine i-131 iobenguane, tx |
Iodine i-131 iobenguane, therapeutic, 1 millicurie |
| C9441 |
Inj, ferric carboxymaltose |
Injection, ferric carboxymaltose, 1 mg |
| C9442 |
Injection, belinostat |
Injection, belinostat, 10 mg |
| C9443 |
Injection, dalbavancin |
Injection, dalbavancin, 10 mg |
| C9444 |
Injection, oritavancin |
Injection, oritavancin, 10 mg |
| C9445 |
C-1 esterase, ruconest |
Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units |
| C9446 |
Inj, tedizolid phosphate |
Injection, tedizolid phosphate, 1 mg |
| C9447 |
Inj, phenylephrine ketorolac |
Injection, phenylephrine and ketorolac, 4 ml vial |
| C9448 |
Oral netupitant palonosetron |
Netupitant 300 mg and palonosetron 0.5 mg, oral |
| C9449 |
Inj, blinatumomab |
Injection, blinatumomab, 1 mcg |
| C9450 |
Fluocinolone acetonide implt |
Injection, fluocinolone acetonide intravitreal implant, 0.01 mg |
| C9451 |
Injection, peramivir |
Injection, peramivir, 1 mg |
| C9452 |
Inj, ceftolozane/tazobactam |
Injection, ceftolozane 50 mg and tazobactam 25 mg |
| C9453 |
Injection, nivolumab |
Injection, nivolumab, 1 mg |
| C9454 |
Inj, pasireotide long acting |
Injection, pasireotide long acting, 1 mg |
| C9455 |
Injection, siltuximab |
Injection, siltuximab, 10 mg |
| C9456 |
Inj, isavuconazonium sulfate |
Injection, isavuconazonium sulfate, 1 mg |
| C9457 |
Lumason contrast agent |
Injection, sulfur hexafluoride lipid microsphere, per ml |
| C9458 |
Florbetaben f18 |
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries |
| C9459 |
Flutemetamol f18 |
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries |
| C9460 |
Injection, cangrelor |
Injection, cangrelor, 1 mg |
| C9461 |
Choline c 11, diagnostic |
Choline c 11, diagnostic, per study dose |
| C9462 |
Injection, delafloxacin |
Injection, delafloxacin, 1 mg |
| C9463 |
Injection, aprepitant |
Injection, aprepitant, 1 mg |
| C9464 |
Injection, rolapitant |
Injection, rolapitant, 0.5 mg |
| C9465 |
Injection, durolane |
Hyaluronan or derivative, durolane, for intra-articular injection, per dose |
| C9466 |
Injection, benralizumab |
Injection, benralizumab, 1 mg |
| C9467 |
Inj rituximab hyaluronidase |
Injection, rituximab and hyaluronidase, 10 mg |
| C9468 |
Inj, factor ix, rebinyn |
Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u. |
| C9469 |
Inj triamcinolone acetonide |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
| C9470 |
Aripiprazole lauroxil im |
Injection, aripiprazole lauroxil, 1 mg |
| C9471 |
Hymovis, 1 mg |
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg |
| C9472 |
Inj talimogene laherparepvec |
Injection, talimogene laherparepvec, 1 million plaque forming units (pfu) |
| C9473 |
Injection, mepolizumab |
Injection, mepolizumab, 1 mg |
| C9474 |
Inj, irinotecan liposome |
Injection, irinotecan liposome, 1 mg |
| C9475 |
Injection, necitumumab |
Injection, necitumumab, 1 mg |
| C9476 |
Injection, daratumumab |
Injection, daratumumab, 10 mg |
| C9477 |
Injection, elotuzumab |
Injection, elotuzumab, 1 mg |
| C9478 |
Injection, sebelipase alfa |
Injection, sebelipase alfa, 1 mg |
| C9479 |
Instill, ciprofloxacin otic |
Instillation, ciprofloxacin otic suspension, 6 mg |
| C9480 |
Injection, trabectedin |
Injection, trabectedin, 0.1 mg |
| C9481 |
Injection, reslizumab |
Injection, reslizumab, 1 mg |
| C9482 |
Sotalol hydrochloride iv |
Injection, sotalol hydrochloride, 1 mg |
| C9483 |
Injection, atezolizumab |
Injection, atezolizumab, 10 mg |
| C9484 |
Injection, eteplirsen |
Injection, eteplirsen, 10 mg |
| C9485 |
Injection, olaratumab |
Injection, olaratumab, 10 mg |
| C9486 |
Inj, granisetron ext |
Injection, granisetron extended release, 0.1 mg |
| C9487 |
Ustekinumab iv inj, 1 mg |
Ustekinumab, for intravenous injection, 1 mg |
| C9488 |
Conivaptan hcl |
Injection, conivaptan hydrochloride, 1 mg |
| C9489 |
Injection, nusinersen |
Injection, nusinersen, 0.1 mg |
| C9490 |
Injection, bezlotoxumab |
Injection, bezlotoxumab, 10 mg |
| C9491 |
Injection, avelumab |
Injection, avelumab, 10 mg |
| C9492 |
Injection, durvalumab |
Injection, durvalumab, 10 mg |
| C9493 |
Injection, edaravone |
Injection, edaravone, 1 mg |
| C9494 |
Injection, ocrelizumab |
Injection, ocrelizumab, 1 mg |
| C9497 |
Loxapine, inhalation powder |
Loxapine, inhalation powder, 10 mg |
| C9507 |
Covid-19 convalescent plasma |
Plasma, high titer covid-19 convalescent, each unit |
| C9600 |
Perc drug-el cor stent sing |
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
| C9601 |
Perc drug-el cor stent bran |
Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) |
| C9602 |
Perc d-e cor stent ather s |
Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch |
| C9603 |
Perc d-e cor stent ather br |
Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) |
| C9604 |
Perc d-e cor revasc t cabg s |
Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel |
| C9605 |
Perc d-e cor revasc t cabg b |
Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure) |
| C9606 |
Perc d-e cor revasc w ami s |
Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel |
| C9607 |
Perc d-e cor revasc chro sin |
Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel |
| C9608 |
Perc d-e cor revasc chro add |
Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure) |
| C9724 |
Eps stomach plic |
Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy |
| C9725 |
Place endorectal app |
Placement of endorectal intracavitary applicator for high intensity brachytherapy |
| C9726 |
Rxt breast appl place/remov |
Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure |
| C9727 |
Insert palate implants |
Insertion of implants into the soft palate; minimum of three implants |
| C9728 |
Place device/marker, non pro |
Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple |
| C9733 |
Non-ophthalmic fva |
Non-ophthalmic fluorescent vascular angiography |
| C9734 |
U/s trtmt, not leiomyomata |
Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance |
| C9735 |
Anoscopy, submucosal inj |
Anoscopy; with directed submucosal injection(s), any substance |
| C9737 |
Lap esoph augmentation |
Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) |
| C9738 |
Blue light cysto imag agent |
Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure) |
| C9739 |
Cystoscopy prostatic imp 1-3 |
Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants |
| C9740 |
Cysto impl 4 or more |
Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants |
| C9741 |
Impl pressure sensor w/angio |
Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report |
| C9742 |
Laryngoscopy with injection |
Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed |
| C9743 |
Bulking/spacer material impl |
Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies) |
| C9744 |
Abd us w/contrast |
Ultrasound, abdominal, with contrast |
| C9745 |
Nasal endo eustachian tube |
Nasal endoscopy, surgical; balloon dilation of eustachian tube |
| C9746 |
Trans imp balloon cont |
Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed |
| C9747 |
Ablation, hifu, prostate |
Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance |
| C9748 |
Prostatic rf water vapor tx |
Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy |
| C9749 |
Repair nasal stenosis w/imp |
Repair of nasal vestibular lateral wall stenosis with implant(s) |
| C9750 |
Ins/rem-replace compl iims |
Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode) |
| C9751 |
Microwave bronch, 3d, ebus |
Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s) |
| C9752 |
Intraosseous des lumb/sacrum |
Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum |
| C9753 |
Intraosseous destruct add'l |
Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure) |
| C9754 |
Perc av fistula, direct |
Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed) |
| C9755 |
Rf magnetic-guide av fistula |
Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed |
| C9756 |
Fluorescence lymph map w/icg |
Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure) |
| C9757 |
Spine device implant surgery |
Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar |
| C9758 |
Blind interatrial shunt ide |
Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study |
| C9759 |
Transcath intraop microinf |
Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed |
| C9760 |
Non-blind interatrial shunt |
Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study |
| C9761 |
Cysto, litho, vacuum kidney |
Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if applicable (must use a steerable ureteral catheter) |
| C9762 |
Cardiac mri seg dys strain |
Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging |
| C9763 |
Cardiac mri seg dys stress |
Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging |
| C9764 |
Revasc intravasc lithotripsy |
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed |
| C9765 |
Revasc intra lithotrip-stent |
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed |
| C9766 |
Revasc intra lithotrip-ather |
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed |
| C9767 |
Revasc lithotrip-stent-ather |
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed |
| C9768 |
Endo us-guide hep porto grad |
Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure) |
| C9769 |
Cysto w/temp pros implant |
Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts |
| C9770 |
Vitrec/mech pars, subret inj |
Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent |
| C9771 |
Nsl/sins cryo post nasal tis |
Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral |
| C9772 |
Revasc lithotrip tibi/perone |
Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed |
| C9773 |
Revasc lithotr-stent tib/per |
Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed |
| C9774 |
Revasc lithotr-ather tib/per |
Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed |
| C9775 |
Revasc lith-sten-ath tib/per |
Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed |
| C9776 |
Fluo bile duct imaging w/icg |
Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure) |
| C9777 |
Esophag muc integ w/eso egd |
Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy |
| C9778 |
Colpopexy, min/inv, ex-perit |
Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous) |
| C9779 |
Esd endoscopy or colonoscopy |
Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed |
| C9780 |
Insert cv cath inf & sup app |
Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance |
| C9781 |
Arthro/shoul surg; w/spacer |
Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed |
| C9782 |
Blind myocar trpl bon marrow |
Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study |
| C9783 |
Blind cor sinus reducer impl |
Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catherization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study |
| C9784 |
Endo sleeve gastro w/tube |
Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components |
| C9785 |
Endo outlet restrict w/tube |
Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components |
| C9786 |
Echo cad for hf preserved ef |
Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report |
| C9787 |
Gastric ep mapg simult pt sx |
Gastric electrophysiology mapping with simultaneous patient symptom profiling |
| C9788 |
Uni breas optoacoustic imag |
Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination |
| C9789 |
Instill pharm renal pelvis |
Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed |
| C9790 |
Kidney histotripsy w/image |
Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance |
| C9791 |
Mri hyperpolarized xenon129 |
Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent |
| C9792 |
Blind/nonblind trans atrial |
Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study) |
| C9793 |
Pre-plan 3d model w/ccta |
3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography with report |
| C9794 |
Complex simulation w/pet-ct |
Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling) |
| C9795 |
Sbrt w/positron emission del |
Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions |
| C9796 |
Rpr intst excl anrect fist |
Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [sis]) |
| C9797 |
Vasc emb/occ w/prs cath |
Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction |
| C9800 |
Dermal filler inj px/suppl |
Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies |
| C9803 |
Hopd covid-19 spec collect |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
| C9898 |
Inpnt stay radiolabeled item |
Radiolabeled product provided during a hospital inpatient stay |
| C9899 |
Inpt implant pros dev,no cov |
Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage |
| C9901 |
Endo defect closure gi tract |
Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components |